These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25572435)

  • 21. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
    Li K; Fichna J; Schicho R; Saur D; Bashashati M; Mackie K; Li Y; Zimmer A; Göke B; Sharkey KA; Storr M
    Neuropharmacology; 2013 Aug; 71(100):255-63. PubMed ID: 23603203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
    Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
    PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent Response to Cannabinoid Receptor Stimulation in High and Low Stress-Induced Analgesia Mouse Lines Is Associated with Differential G-Protein Activation.
    Lesniak A; Chmielewska D; Poznanski P; Bujalska-Zadrozny M; Strzemecka J; Sacharczuk M
    Neuroscience; 2019 Apr; 404():246-258. PubMed ID: 30794845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
    Michalski CW; Laukert T; Sauliunaite D; Pacher P; Bergmann F; Agarwal N; Su Y; Giese T; Giese NA; Bátkai S; Friess H; Kuner R
    Gastroenterology; 2007 May; 132(5):1968-78. PubMed ID: 17484889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
    Fichna J; Sałaga M; Stuart J; Saur D; Sobczak M; Zatorski H; Timmermans JP; Bradshaw HB; Ahn K; Storr MA
    Neurogastroenterol Motil; 2014 Apr; 26(4):470-81. PubMed ID: 24460851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.
    Storr MA; Bashashati M; Hirota C; Vemuri VK; Keenan CM; Duncan M; Lutz B; Mackie K; Makriyannis A; Macnaughton WK; Sharkey KA
    Neurogastroenterol Motil; 2010 Jul; 22(7):787-96, e223. PubMed ID: 20180825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.
    Fichna J; Dicay M; Lewellyn K; Janecka A; Zjawiony JK; MacNaughton WK; Storr MA
    Inflamm Bowel Dis; 2012 Jun; 18(6):1137-45. PubMed ID: 21953882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of rat VD-hemopressin(α), an α-hemoglobin-derived peptide exhibiting cannabinoid agonist-like effects in mice.
    Zheng T; Zhang T; Zhang R; Wang ZL; Han ZL; Li N; Li XH; Zhang MN; Xu B; Yang XL; Fang Q; Wang R
    Neuropeptides; 2017 Jun; 63():83-90. PubMed ID: 28010996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structures of agonist-bound human cannabinoid receptor CB
    Hua T; Vemuri K; Nikas SP; Laprairie RB; Wu Y; Qu L; Pu M; Korde A; Jiang S; Ho JH; Han GW; Ding K; Li X; Liu H; Hanson MA; Zhao S; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
    Nature; 2017 Jul; 547(7664):468-471. PubMed ID: 28678776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.
    Chin CL; Tovcimak AE; Hradil VP; Seifert TR; Hollingsworth PR; Chandran P; Zhu CZ; Gauvin D; Pai M; Wetter J; Hsieh GC; Honore P; Frost JM; Dart MJ; Meyer MD; Yao BB; Cox BF; Fox GB
    Br J Pharmacol; 2008 Jan; 153(2):367-79. PubMed ID: 17965748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
    Brizzi A; Aiello F; Marini P; Cascio MG; Corelli F; Brizzi V; De Petrocellis L; Ligresti A; Luongo L; Lamponi S; Maione S; Pertwee RG; Di Marzo V
    Bioorg Med Chem; 2014 Sep; 22(17):4770-83. PubMed ID: 25065940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel derivatives of 1,2,3-triazole, cannabinoid-1 receptor ligands modulate gastrointestinal motility in mice.
    Szymaszkiewicz A; Zielinska M; Li K; Ramanathan M; Alam S; Hou DR; Fichna J; Storr M
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):435-444. PubMed ID: 29404698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
    Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
    Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210.
    Serrano A; Vadas E; Ferrer B; Bilbao A; Granado N; Suárez J; Pavon FJ; Moratalla R; Rodríguez de Fonseca F
    Psychopharmacology (Berl); 2021 Feb; 238(2):551-557. PubMed ID: 33410990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice.
    Fichna J; Sibaev A; Sałaga M; Sobczak M; Storr M
    Neurogastroenterol Motil; 2013 Aug; 25(8):e550-9. PubMed ID: 23692073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ
    De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F
    Neuropharmacology; 2020 Nov; 179():108287. PubMed ID: 32860777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of cannabinoid receptor agonists and a cyclooxygenase-2 inhibitor in rat bone tumor pain.
    Cui JH; Ju J; Yoon MH
    Pharmacology; 2013; 92(3-4):150-7. PubMed ID: 24008428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations.
    Jung SW; Cho AE; Yu W
    Sci Rep; 2018 Sep; 8(1):13787. PubMed ID: 30213978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.